Nuvama Wealth Management Allots 1,38,099 Equity Shares Under ESOP and ESAR Schemes

Nuvama Wealth Management Limited announced on May 11, 2026, the allotment of 1,38,099 equity shares to eligible employees following the exercise of stock options and stock appreciation rights under its Employee Stock Option Scheme(s) and Employee Stock Appreciation Rights Plan. The allotment was approved by the company on the same date and disclosed to stock exchanges in compliance with Regulation 30.

Share Capital Expansion

Each allotted share carries a face value of Rs. 2 and is fully paid-up. The allotment has resulted in a corresponding increase in the company's total issued equity share capital. The following table summarises the change in share capital:

Metric: Details Shares Allotted: 1,38,099 Face Value per Share: Rs. 2 Share Capital (Pre-Allotment): 18,20,41,513 equity shares Share Capital (Post-Allotment): 18,21,79,612 equity shares Allotment Date: May 11, 2026 Scheme: Employee Stock Option Scheme(s) and Employee Stock Appreciation Rights Plan

Regulatory Disclosure

The intimation was filed with BSE Limited and the National Stock Exchange of India Ltd. as required under the applicable listing regulations. The disclosure was signed by Sneha Patwardhan, Company Secretary and Compliance Officer of Nuvama Wealth Management Limited, on May 11, 2026.

Nuvama Wealth Management Limited announced on May 11, 2026, the grant of 93,930 Employee Stock Appreciation Rights (ESARs) to eligible employees under the 'Nuvama Wealth Employee Stock Appreciation Rights Plan 2024'. The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in accordance with SEBI Master Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Key Details of the ESAR Grant

The grant covers not more than 93,930 equity shares of the company and is compliant with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The following table summarises the key parameters of the grant:

Parameter: Details Number of ESARs Granted: 93,930 Total Shares Covered: Not more than 93,930 equity shares Grant Date: May 11, 2026 Plan Name: Nuvama Wealth Employee Stock Appreciation Rights Plan 2024 ESARs Vested: Nil Exercise Period: 2 years from the date of vesting Administering Body: Nomination and Remuneration Committee SEBI Regulations Compliance: SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021

Pricing Formula and Settlement Terms

The ESAR price for each grant is determined by the Nomination and Remuneration Committee. It is calculated as the average of the daily opening and closing price of the company's equity shares, as quoted on the recognised stock exchange where the trading volume is higher, across each of the 20 trading days immediately prior to the relevant date.

Once vested and exercised, the ESARs entitle the holder to receive appreciation on a specified number of equity shares of the company. Settlement of such appreciation is made in the form of equity shares of the company, upon payment of the exercise price and applicable taxes, in accordance with the terms and conditions of the Plan.

Applicable Disclosures

Since the current disclosure pertains solely to the grant of ESARs, several parameters are not applicable at this stage. These include:

ESARs exercised

Money realised by exercise of ESARs

Total shares arising from exercise of ESARs

ESARs lapsed

Subsequent changes, cancellation, or exercise of ESARs

Diluted earnings per share pursuant to the issue of equity shares on exercise of ESARs

No variation of terms has been reported in connection with this grant. The disclosure was signed by Sneha Patwardhan, Company Secretary and Compliance Officer of Nuvama Wealth Management Limited.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.